Milestone Pharmaceuticals Inc.(MIST)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MIST Milestone Pharmaceuticals Inc.

交易中 03-03 10:11:47 EST

1.67

-0.06

-3.76%

最高1.70	最低1.65	成交量23.40万
今开1.68	昨收1.73	日振幅2.89%
总市值1.42亿	流通市值1.31亿	总股本8,517万
成交额39.13万	换手率0.30%	流通股本7,881万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"MIST","market":"US","secType":"STK","nameCN":"Milestone Pharmaceuticals Inc.","latestPrice":1.665,"timestamp":1772550621095,"preClose":1.73,"halted":0,"volume":234017,"delay":0,"changeRate":-0.03757225433526008,"floatShares":78814500,"shares":85169344,"eps":-0.79,"marketStatus":"交易中","change":-0.065,"latestTime":"03-03 10:11:47 EST","open":1.68,"high":1.7,"low":1.65,"amount":391266.7356962,"amplitude":0.028902,"askPrice":1.67,"askSize":4998,"bidPrice":1.66,"bidSize":400,"shortable":3,"etf":0,"ttmEps":-0.79,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1772571600000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1557374400000,"exchange":"NASDAQ","adjPreClose":1.73,"preHourTrading":{"tag":"盘前","latestPrice":1.68,"preClose":1.73,"latestTime":"09:27 EST","volume":2132,"amount":3596.178716,"timestamp":1772548060028,"change":-0.05,"changeRate":-0.028902,"amplitude":0.027977},"postHourTrading":{"tag":"盘后","latestPrice":1.7418,"preClose":1.73,"latestTime":"19:31 EST","volume":8148,"amount":14250.331,"timestamp":1772497883989,"change":0.0118,"changeRate":0.006821,"amplitude":0.011561},"volumeRatio":1.598725,"impliedVol":5.5541,"impliedVolPercentile":0.9801},"requestUrl":"/m/hq/s/MIST","defaultTab":"news","newsList":[{"id":"1146653833","title":"里程碑制药公司宣布将于2026年2月中旬启动Cardamyst全国销售团队部署","url":"https://stock-news.laohu8.com/highlight/detail?id=1146653833","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146653833?lang=zh_cn&edition=full","pubTime":"2026-01-26 21:06","pubTimestamp":1769432784,"startTime":"0","endTime":"0","summary":"里程碑制药公司（Milestone Pharmaceuticals Inc.）近日披露，其针对创新药物Cardamyst的全国销售团队部署计划已正式敲定，将于2026年2月中旬全面启动。这一战略举措标志着公司核心产品商业化进程进入关键阶段，为潜在的市场渗透与营收增长奠定基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MIST"],"gpt_icon":0},{"id":"2603809346","title":"Milestone Pharmaceuticals Inc.盘中异动 股价大跌5.39%报1.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603809346","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603809346?lang=zh_cn&edition=full","pubTime":"2026-01-12 22:45","pubTimestamp":1768229138,"startTime":"0","endTime":"0","summary":"北京时间2026年01月12日22时45分，Milestone Pharmaceuticals Inc.股票出现异动，股价急速跳水5.39%。截至发稿，该股报1.93美元/股，成交量89.5765万股，换手率1.05%，振幅5.39%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为1.00%。Milestone Pharmaceuticals Inc.公司简介：Milestone Pharmaceuticals Inc是一家生物制药公司，致力于开发和商业化用于心血管药物治疗的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112224539a4bb19c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112224539a4bb19c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MIST","BK4007"],"gpt_icon":0},{"id":"1121250450","title":"Milestone Pharmaceuticals Inc.宣布欧洲药品管理局受理其鼻喷雾剂Etripamil用于PSVT的上市授权申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1121250450","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1121250450?lang=zh_cn&edition=full","pubTime":"2026-01-06 21:03","pubTimestamp":1767704607,"startTime":"0","endTime":"0","summary":"Milestone Pharmaceuticals Inc.宣布，其用于治疗阵发性室上性心动过速（PSVT）的鼻喷雾剂Etripamil的上市授权申请，已获得欧洲药品管理局（EMA）的正式受理。这一关键进展标志着该药物在欧洲监管审批流程中迈出了重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MIST"],"gpt_icon":0},{"id":"1120815867","title":"米尔斯通制药股价在盘前交易中上涨34.8%，因FDA批准其心律鼻喷雾剂","url":"https://stock-news.laohu8.com/highlight/detail?id=1120815867","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120815867?lang=zh_cn&edition=full","pubTime":"2025-12-15 21:07","pubTimestamp":1765804032,"startTime":"0","endTime":"0","summary":"米尔斯通制药股价在盘前交易中上涨34.8%，因FDA批准其心律鼻喷雾剂。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MIST"],"gpt_icon":0},{"id":"1182401118","title":"Milestone获得FDA批准Cardamyst™ (Etripamil)成为首个也是唯一的自我给药鼻喷雾剂，用于治疗成人阵发性室上性心动过速（Psvt）","url":"https://stock-news.laohu8.com/highlight/detail?id=1182401118","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182401118?lang=zh_cn&edition=full","pubTime":"2025-12-13 09:01","pubTimestamp":1765587676,"startTime":"0","endTime":"0","summary":"Milestone获得FDA批准Cardamyst™ (Etripamil)成为首个也是唯一的自我给药鼻喷雾剂，用于治疗成人阵发性室上性心动过速（Psvt）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MIST"],"gpt_icon":0},{"id":"2586265732","title":"Milestone Pharmaceuticals Inc.盘中异动 早盘股价大涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586265732","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586265732?lang=zh_cn&edition=full","pubTime":"2025-11-26 23:01","pubTimestamp":1764169316,"startTime":"0","endTime":"0","summary":"北京时间2025年11月26日23时01分，Milestone Pharmaceuticals Inc.股票出现波动，股价快速上涨5.06%。截至发稿，该股报2.60美元/股，成交量74.313万股，换手率0.87%，振幅6.07%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.03%。Milestone Pharmaceuticals Inc.公司简介：Milestone Pharmaceuticals Inc是一家生物制药公司，致力于开发和商业化用于心血管药物治疗的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126230156951be166&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126230156951be166&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MIST"],"gpt_icon":0},{"id":"2585170146","title":"Milestone Pharmaceuticals Inc.盘中异动 股价大涨5.19%报2.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2585170146","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585170146?lang=zh_cn&edition=full","pubTime":"2025-11-22 01:44","pubTimestamp":1763747091,"startTime":"0","endTime":"0","summary":"北京时间2025年11月22日01时44分，Milestone Pharmaceuticals Inc.股票出现异动，股价急速拉升5.19%。截至发稿，该股报2.43美元/股，成交量167.259万股，换手率1.96%，振幅7.14%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为1.00%。Milestone Pharmaceuticals Inc.公司简介：Milestone Pharmaceuticals Inc是一家生物制药公司，致力于开发和商业化用于心血管药物治疗的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251122014451a4b21cc3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251122014451a4b21cc3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MIST","BK4007"],"gpt_icon":0},{"id":"2584087137","title":"Milestone Pharmaceuticals Inc.盘中异动 股价大跌5.19%报2.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584087137","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584087137?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:35","pubTimestamp":1763570130,"startTime":"0","endTime":"0","summary":"北京时间2025年11月20日00时35分，Milestone Pharmaceuticals Inc.股票出现波动，股价急速下跌5.19%。截至发稿，该股报2.29美元/股，成交量152.69万股，换手率1.79%，振幅6.87%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.94%。Milestone Pharmaceuticals Inc.公司简介：Milestone Pharmaceuticals Inc是一家生物制药公司，致力于开发和商业化用于心血管药物治疗的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120003530950ed14c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120003530950ed14c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MIST","BK4007"],"gpt_icon":0},{"id":"2582891368","title":"Milestone Pharmaceuticals Inc.盘中异动 大幅上涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582891368","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582891368?lang=zh_cn&edition=full","pubTime":"2025-11-10 22:34","pubTimestamp":1762785298,"startTime":"0","endTime":"0","summary":"北京时间2025年11月10日22时34分，Milestone Pharmaceuticals Inc.股票出现波动，股价快速拉升5.26%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.55%。其相关个股中，Cogent Biosciences, Inc.、Inflarx N.V.、Briacell Therapeutics Corp C/Wts 涨幅较大，Inflarx N.V.、Propanc Biopharma, Inc.、Innate Pharma较为活跃，换手率分别为76.72%、15.20%、8.69%，振幅较大的相关个股有Cogent Biosciences, Inc.、Inflarx N.V.、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为20.18%、17.89%、13.27%。Milestone Pharmaceuticals Inc.公司简介：Milestone Pharmaceuticals Inc是一家生物制药公司，致力于开发和商业化用于心血管药物治疗的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111022345894fb948c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111022345894fb948c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MIST"],"gpt_icon":0},{"id":"2581009526","title":"Milestone Pharmaceuticals Inc.盘中异动 大幅跳水5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581009526","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581009526?lang=zh_cn&edition=full","pubTime":"2025-11-07 00:34","pubTimestamp":1762446885,"startTime":"0","endTime":"0","summary":"北京时间2025年11月07日00时34分，Milestone Pharmaceuticals Inc.股票出现异动，股价快速下挫5.00%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.93%。其相关个股中，Surrozen Inc C/Wts 01/08/2031 、Iovance Biotherapeutics, Inc.、Tectonic Therapeutic, Inc.涨幅较大，Osr Holdings, Inc.、Bio Green Med Solution, Inc.、Enveric Biosciences, Inc.较为活跃，换手率分别为104.45%、16.03%、15.86%，振幅较大的相关个股有Cytomed Therapeutics Limited、Surrozen Inc C/Wts 01/08/2031 、Genelux Corporation，振幅分别为62.56%、53.54%、40.28%。Milestone Pharmaceuticals Inc.公司简介：Milestone Pharmaceuticals Inc是一家生物制药公司，致力于开发和商业化用于心血管药物治疗的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107003445975890a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107003445975890a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MIST","BK4007"],"gpt_icon":0},{"id":"2561419274","title":"Milestone Pharmaceuticals Inc.盘中异动 股价大涨5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2561419274","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561419274?lang=zh_cn&edition=full","pubTime":"2025-08-21 23:44","pubTimestamp":1755791086,"startTime":"0","endTime":"0","summary":"北京时间2025年08月21日23时44分，Milestone Pharmaceuticals Inc.股票出现异动，股价快速上涨5.18%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.89%。其相关个股中，Protagenic Therapeutics Inc C/Wts 26/04/2026 、知临集团、Protagenic Therapeutics, Inc.涨幅较大，Protagenic Therapeutics, Inc.、知临集团、Tharimmune, Inc.较为活跃，换手率分别为14948.30%、3414.47%、1305.67%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、Protagenic Therapeutics, Inc.、知临集团，振幅分别为459.84%、116.23%、113.39%。Milestone Pharmaceuticals Inc.公司简介：Milestone Pharmaceuticals Inc是一家生物制药公司，致力于开发和商业化用于心血管药物治疗的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082123444694f2886b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082123444694f2886b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MIST","BK4007"],"gpt_icon":0},{"id":"2518222686","title":"Milestone Pharmaceuticals Inc.盘中异动 早盘股价大涨6.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518222686","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518222686?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:31","pubTimestamp":1741613467,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时31分，Milestone Pharmaceuticals Inc.股票出现异动，股价快速上涨6.47%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.59%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为1793.97%、381.32%、45.05%，振幅较大的相关个股有Xencor, Inc.、Y-Mabs Therapeutics, Inc.、Savara, Inc.，振幅分别为99.13%、94.67%、6.60%。Milestone Pharmaceuticals Inc.公司简介：Milestone Pharmaceuticals Inc是一家生物制药公司，致力于开发和商业化用于治疗心血管适应症的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021310798a29c84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021310798a29c84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MIST","BK4007"],"gpt_icon":0},{"id":"2517164681","title":"Milestone Pharmaceuticals Inc.盘中异动 早盘大幅上涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517164681","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517164681?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:45","pubTimestamp":1741272315,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时45分，Milestone Pharmaceuticals Inc.股票出现异动，股价大幅拉升5.05%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.47%。其相关个股中，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Aditxt, Inc.较为活跃，换手率分别为1299.07%、269.27%、59.20%，振幅较大的相关个股有Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Tonix Pharmaceuticals Holding Corp.，振幅分别为33.60%、30.53%、25.56%。Milestone Pharmaceuticals Inc.公司简介：Milestone Pharmaceuticals Inc是一家生物制药公司，致力于开发和商业化用于治疗心血管适应症的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306224515963c502c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306224515963c502c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MIST","BK4007"],"gpt_icon":0},{"id":"2517332948","title":"Milestone Pharmaceuticals Inc.盘中异动 股价大涨6.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517332948","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517332948?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:45","pubTimestamp":1741185917,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时45分，Milestone Pharmaceuticals Inc.股票出现异动，股价急速上涨6.09%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.83%。其相关个股中，Chimerix, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Celularity Inc C/Wts 16/07/2026 涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为485.44%、266.21%、209.56%，振幅较大的相关个股有Silexion Therapeutics Corp、Aditxt, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 ，振幅分别为26.13%、23.90%、22.67%。Milestone Pharmaceuticals Inc.公司简介：Milestone Pharmaceuticals Inc是一家生物制药公司，致力于开发和商业化用于治疗心血管适应症的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224518a260cc73&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224518a260cc73&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MIST"],"gpt_icon":0},{"id":"2516634209","title":"Milestone Pharmaceuticals Inc.盘中异动 早盘急速上涨6.13%报1.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516634209","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516634209?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:31","pubTimestamp":1741012316,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时31分，Milestone Pharmaceuticals Inc.股票出现波动，股价快速拉升6.13%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.21%。其相关个股中，Entero Therapeutics Inc.、Alto Neuroscience, Inc.、Geovax Labs, Inc.涨幅较大，Allarity Therapeutics, Inc.、Entero Therapeutics Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为47.17%、23.41%、22.45%，振幅较大的相关个股有Entero Therapeutics Inc.、Cibus, Inc.、Galmed Pharmaceuticals Ltd.，振幅分别为11.70%、9.55%、9.35%。Milestone Pharmaceuticals Inc.公司简介：Milestone Pharmaceuticals Inc是一家生物制药公司，致力于开发和商业化用于治疗心血管适应症的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223156a25d3fd6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223156a25d3fd6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MIST"],"gpt_icon":0},{"id":"2516705723","title":"Milestone Pharmaceuticals Inc.盘中异动 下午盘股价大跌5.17%报1.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516705723","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516705723?lang=zh_cn&edition=full","pubTime":"2025-03-01 02:15","pubTimestamp":1740766537,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日02时15分，Milestone Pharmaceuticals Inc.股票出现异动，股价快速下跌5.17%。截至发稿，该股报1.65美元/股，成交量55.6161万股，换手率1.04%，振幅7.24%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Milestone Pharmaceuticals Inc.公司简介：Milestone Pharmaceuticals Inc是一家生物制药公司，致力于开发和商业化用于治疗心血管适应症的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301021537a258372d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301021537a258372d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MIST"],"gpt_icon":0},{"id":"2514701532","title":"Milestone Pharmaceuticals Inc.盘中异动 股价大跌5.03%报1.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514701532","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514701532?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:17","pubTimestamp":1740496659,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时17分，Milestone Pharmaceuticals Inc.股票出现异动，股价快速下挫5.03%。截至发稿，该股报1.80美元/股，成交量27.3828万股，换手率0.51%，振幅5.81%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.86%。Milestone Pharmaceuticals Inc.公司简介：Milestone Pharmaceuticals Inc是一家生物制药公司，致力于开发和商业化用于治疗心血管适应症的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225231739abdc89d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225231739abdc89d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MIST"],"gpt_icon":0},{"id":"2509708209","title":"Milestone Pharmaceuticals Inc.盘中异动 临近午盘急速拉升5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509708209","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509708209?lang=zh_cn&edition=full","pubTime":"2025-02-07 00:56","pubTimestamp":1738861001,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日00时56分，Milestone Pharmaceuticals Inc.股票出现波动，股价快速拉升5.07%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，Lipella Pharmaceuticals Inc.、Geovax Labs Inc C/Wts 29/09/2025、Palatin Technologies, Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Azitra Inc较为活跃，换手率分别为5946.75%、1569.09%、159.86%，振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Palatin Technologies, Inc.，振幅分别为125.58%、53.02%、49.54%。Milestone Pharmaceuticals Inc.公司简介：Milestone Pharmaceuticals Inc是一家生物制药公司，致力于开发和商业化用于治疗心血管适应症的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207005641abc4f274&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207005641abc4f274&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MIST"],"gpt_icon":0},{"id":"2509251110","title":"Milestone Pharmaceuticals Inc.盘中异动 临近收盘股价大涨5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509251110","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509251110?lang=zh_cn&edition=full","pubTime":"2025-02-06 04:57","pubTimestamp":1738789060,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日04时57分，Milestone Pharmaceuticals Inc.股票出现异动，股价急速上涨5.53%。截至发稿，该股报2.10美元/股，成交量52.9177万股，换手率0.99%，振幅5.02%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为1.97%。Milestone Pharmaceuticals Inc.公司简介：Milestone Pharmaceuticals Inc是一家生物制药公司，致力于开发和商业化用于治疗心血管适应症的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206045740abc3cc60&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206045740abc3cc60&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MIST"],"gpt_icon":0},{"id":"2508993347","title":"Milestone Pharmaceuticals Inc.盘中异动 快速下挫5.94%报1.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508993347","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508993347?lang=zh_cn&edition=full","pubTime":"2025-02-01 01:34","pubTimestamp":1738344890,"startTime":"0","endTime":"0","summary":"北京时间2025年02月01日01时34分，Milestone Pharmaceuticals Inc.股票出现异动，股价急速下挫5.94%。截至发稿，该股报1.90美元/股，成交量62.4932万股，换手率1.17%，振幅5.45%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为1.69%。Milestone Pharmaceuticals Inc.公司简介：Milestone Pharmaceuticals Inc是一家生物制药公司，致力于开发和商业化用于治疗心血管适应症的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250201013451a235625b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250201013451a235625b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MIST"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.milestonepharma.com","stockEarnings":[{"period":"1week","weight":0.0237},{"period":"1month","weight":-0.0942},{"period":"3month","weight":-0.3472},{"period":"6month","weight":-0.0281},{"period":"1year","weight":0.0613},{"period":"ytd","weight":-0.1436}],"compareEarnings":[{"period":"1week","weight":0.0058},{"period":"1month","weight":-0.0081},{"period":"3month","weight":0.0071},{"period":"6month","weight":0.0662},{"period":"1year","weight":0.1552},{"period":"ytd","weight":0.0065}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Milestone Pharmaceuticals Inc.于2003年根据魁北克省法律注册成立。该公司是一家专注于心血管创新药物开发和商业化的生物制药公司。公司主导候选产品曲立帕米是一种新型强效钙通道阻滞剂，他们将其设计为一种快速起效的鼻腔喷雾剂，供患者自行给药。该公司正在开发用于治疗特定心律失常的曲立帕米，其主要适应症是治疗阵发性室上性心动过速，或PSVT，随后的适应症是治疗具有快速心室率的心房颤动，或AFIB-RVR。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.028702},{"month":2,"riseRate":0.142857,"avgChangeRate":-0.116389},{"month":3,"riseRate":0.571429,"avgChangeRate":-0.140862},{"month":4,"riseRate":0.666667,"avgChangeRate":0.196115},{"month":5,"riseRate":0.666667,"avgChangeRate":0.024602},{"month":6,"riseRate":0.571429,"avgChangeRate":0.044863},{"month":7,"riseRate":0.714286,"avgChangeRate":0.159669},{"month":8,"riseRate":0.571429,"avgChangeRate":0.085263},{"month":9,"riseRate":0.571429,"avgChangeRate":0.012421},{"month":10,"riseRate":0.142857,"avgChangeRate":-0.130693},{"month":11,"riseRate":0.571429,"avgChangeRate":0.153201},{"month":12,"riseRate":0.285714,"avgChangeRate":-0.087166}],"exchange":"NASDAQ","name":"Milestone Pharmaceuticals Inc.","nameEN":"Milestone Pharmaceuticals Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Milestone Pharmaceuticals Inc.(MIST)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Milestone Pharmaceuticals Inc.(MIST)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Milestone Pharmaceuticals Inc.,MIST,Milestone Pharmaceuticals Inc.股票,Milestone Pharmaceuticals Inc.股票老虎,Milestone Pharmaceuticals Inc.股票老虎国际,Milestone Pharmaceuticals Inc.行情,Milestone Pharmaceuticals Inc.股票行情,Milestone Pharmaceuticals Inc.股价,Milestone Pharmaceuticals Inc.股市,Milestone Pharmaceuticals Inc.股票价格,Milestone Pharmaceuticals Inc.股票交易,Milestone Pharmaceuticals Inc.股票购买,Milestone Pharmaceuticals Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Milestone Pharmaceuticals Inc.(MIST)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Milestone Pharmaceuticals Inc.(MIST)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}